Scribe’s CRISPR-based cholesterol reduction therapy is part of a three-pronged approach to combating cardiovascular disease. Genetic medicine biotech Scribe Therapeutics…
The Scientist’s Top Innovations competition honors the most exciting breakthroughs shaping the future of research, biotechnology, and healthcare. From cutting-edge…
